Differentiated thyroid carcinoma referred for radioiodine therapy

Saudi Medical Journal

Volumn 22, Issue 6, 2001, Pages 497-503

  Al Balawi, Ibrahim A ^a   Meir, Hadir M ^a   Yousef, Mohammed K ^a   Nayel, Hala A ^a   Al Mobarak, Mohammed F ^a  

^a King Abdulaziz Hosp and Oncology Centre   (Saudi Arabia)

Author keywords

Radioiodine therapy; Thyroid cancer; Thyroidectomy

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL EXAMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; PATIENT REFERRAL; RADIATION DOSE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0034915163     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med 1998; 338: 297-306.
2. Cancer Incidence Report, Saudi Arabia. 1994-1996. Depositary number in King Fahad National Libray : 0110/16. Kingdom of Saudi Arabia: National Cancer Registry: 1999.
3. De velde LJ, Hamming JF, Goslings BM, Schelfhout LJ, Clark OH, Smeds et al. Report of the conserves development conference on the management of differentiated thyroid cancer in the Netherlands. Eur J Clin Oncol 1988; 24: 287-392.
4. Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 1996; 81: 333-339.
5. Fraker DL, Skarulis M, Livolsi V. Thyroid tumours. In: Devita VT, Hellman S Jr, Rosenberg SA, editors. Cancer, Principle and practice of Oncology. 5th ed Philadelphia; Lippincott Raven Publishers; 1997, p.1629.
6. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma. A study of 535 cases observed in a 50 year period. Surgery 1992; 112: 1139-1146.
7. Samaan NA, Schultz PN, Hickey RC, Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75: 714-720.
8. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma. Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050-1058.
9. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O'Sullivan B. A comparaison of different staging systems predictability of patient outcome thyroid carcinoma as an example. Cancer 1997; 79: 2414-2423.
10. Coburn MC, Wanebo HJ. Age correlates with increased frequency of high risk factors. Am J Surg 1995; 170: 471-475.
11. Mazzaferri EL. Radioiodine and other treatment and outcomes. In. Braverman LE, Utiger RD editors. The Thyroid. A fundamental and Clinical text. 6th ed. Philadelphia: JB Lippincott Co; 1991. p. 1138-1165.
12. Degroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 414-424.
13. Filesi M, Signore A, Ventroni G. Role of initial iodiodine 131 wholebody scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998; 39: 1542-1546.
14. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester J, Fremgen A. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990; 160: 344-351.
15. McHenry CR, Rosen IB, Walfish PE. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991; 162: 353-358.
16. Grebe SK, Hay ID. Thyroid cancer nodal metastases: Biologic significance and therapeutic considerations. Sur Oncol Clin N Am 1996; 5: 43-63.
17. Schelfout LJ, Creutzberg CL, Hamming JF, Fleuren G, Smeenk D, Hermans J, Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988; 24: 331-335.
18. Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Survival and cause of death in thyroid cancer: a population - based study of 2479 casaes from Norway. Cancer Res 1991; 51: 1234-1241.
19. Farahati J, Reiners C, Stuschke M, Muller SP, Stuben G, Sauerwein W, Differentiated thyroid cancer: Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage p T4). Cancer 1996; 77: 172-180.
20. Lerch H, Schober U, Kovert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997; 15: 2067-2075.
21. Anderson PE, Kinsella J, Loree TR, Shah AR, Shah JP. Differentiated carcinoma of the thyroid with extra thyroid extension. Am J Surg 1995; 170: 467-470.
22. Moreno A, Rodriguez JM, Sola J, Soria T, Parilla P. Multivariate analysis of histopahtological features as prognostic factors in patient with papillary thyroid carcinoma. Br J Surg 1995; 82: 1092-1094.
23. Tsuchiy A, Suzuki S, Kanno M, Kikuchi Y, Ando Y, Abe R. Prognostaic factors associated with differentiated thyroid cancer. Surg Today 1995; 25: 778-782.
24. Cady B. Thyroid neoplasms. In: Sedgwick CE, Cady B editors. Surgery of the thyroid and parathyroid glands. 2nd ed. Philadelphia: WB Saunders: 1980. p. 131.
25. De groot LJ, Reilly M. Comparison of 30 and 50 mCi doses of iodine 131 for thyroid ablation. Ann Intern Med 1982; 96: 51-53.
26. Synder J, Gorman C, Scanlon P. Thyroid remnant ablation: Questionable pursuit of an ill-defined goal. J Nucl Med 1983; 24: 659-665.
27. Beierwaltes WH, Rabbani R, Mouchowskic D, Lloyd RV, Eyre P, Mallettes S. An analysis of ablation of thyroid remnants with I-131 in 511 patients from 1947-1984: Experience of University of Michigan. J Nucl Med 1984; 25: 1287-1293.
28. Mohammadi H, Saghari M. Hospital discharge policy in thyroid cancer patients treated with I131 : The effect of changing from fuxed time to exposure rate threshold. Health Phys 1997; 72: 476-480.
29. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J. Iodine 131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995; 80: 1488-1492.
30. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma Cancer Control. JMCC 2000; 7: 229-239.